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Abstract 
Background and Purpose: The present body of literature has little information regarding factors behind 
gaps in health status affecting Asian American, Native Hawaiian and Pacific Islander (AANHPI) 
communities, and methods to address them.  We sought to examine pharmacists’ and other health care 
professionals’ perceptions of AANHPI health disparities and their ideas for solutions involving 
pharmacists, pharmacy schools, and the U.S. Food and Drug Administration (FDA).  
Methods: In-depth individual interviews were conducted with ten academic pharmacists and four other 
health care professionals knowledgeable about AANHPI disparities, with a focus on medication-related 
disparities.  
Results: Commonly identified factors behind disparities included poor communication, low 
socioeconomic status, cultural inhibitions creating a reluctance to seek care, and limited access to care. 
Suggested strategies for community pharmacists to reduce disparities included one-on-one care focused 
on outcomes, translated materials and translation services, and tracking adherence to medications. 
Participants suggested that colleges of pharmacy could continue community health events, encourage 
students to be culturally aware, and conduct health disparities research, and that the FDA could provide 
translated information, research funding, and requirements for greater ethnic diversity in clinical trials. 
Conclusion: Experts believe that pharmacists have the potential to help close the health care gap for 
AANHPI populations. 
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Introduction 
 
Asian Americans, Native Hawaiians, and Pacific 
Islanders (AANHPIs) are a rapidly growing 
portion of the population in the United States. 
Quantitative data are increasingly being 
generated documenting health disparities 
affecting AANHPIs in many areas including 
diabetes, hepatitis B, and tuberculosis (Moy, 
Sallis, & David, 2010; Weir, Tseng, Yen, & 
Caballero, 2009). AANHPIs have lower levels 
of physical activity, worse diets, higher tobacco 
use, and higher rates of obesity and chronic 
conditions (Moy, Sallis, & David, 2010). Life 
expectancies for Pacific Islanders are lower than 
white mainland populations (Moy, Sallis, &  
 
 
David, 2010). Compared to white mainland 
populations, AANHPI populations have lower 
health literacy (Moy, Sallis, & David, 2010). In 
a report analyzing trends in ethnic disparities in 
medical care, Flores and Lin reported, “[Asian 
and Pacific Islander] children have especially 
high odds of the [primary care physician] never 
spending enough time with the child, receiving 
no specialty care, and receiving no mental 
healthcare” (Flores & Lin, 2013). Native 
Hawaiians and Pacific Islanders have a greater 
prevalence of diabetes compared with non-
Hispanic whites (Centers for Disease Control 
and Prevention, 2013).  
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Despite the growing body of literature 
documenting the disparity in health status 
between AANHPI (most of this conducted in 
Hawaii and the South Pacific), there is little 
information regarding reasons for these 
disparities and ways to address them (Harrigan, 
Ease, LeSaux, Millar, Kagihara, & Shoemaker, 
2005; Hirano, 2012). While studies have been 
conducted examining interventions to improve 
medication adherence in minority populations, 
few have included AANHPIs, who are less 
likely to be included in clinical studies than 
persons of European descent (Manias & 
Willams, 2010; Dachs, 2008). Medication 
adherence is an important aspect of appropriate 
management of chronic disease and is correlated 
with health outcomes and mortality (Simpson, 
Eurich, Majumdar, Padwal, Tsuyuki, Varney, et 
al., 2006).  
 
The 2010 US Census showed that 5.6% of 
Americans identified as Asian and 0.4% of 
Americans identified as NHPI, and that these 
populations grew more than four times faster 
and three times faster than the general US 
population, respectively. The state of Hawaii has 
a large number of AANHPI persons, where 
Asians represent over 50% of the population in 
Hawaii. Additionally, over 50% of NHPIs in the 
United States live in Hawaii and California 
(Census Briefs, 2010).  
 
While quantitative studies are necessary to 
document health disparities, a qualitative 
approach is useful in examining issues of why 
these disparities exist and persist. Using a 
qualitative approach, issues can be examined in 
detail and in depth and data based on human 
experience that is obtained is powerful and 
sometimes more compelling than quantitative 
data. Moreover, subtleties and complexities 
about research subjects and/or topic are 
discovered that are often missed by more 
quantitative inquiries. A recent example of this 
type of work is found in a recent qualitative 
study by Pobutsky and colleagues who 
investigated factors behind health disparities 
among Filipinos in Hawaii. The authors note 
that “there is a lack of information on what 
factors make Filipinos vulnerable to health 
disparities”, and this commentary on Filipino 
health is representative of a broader lack of 
representation and information regarding such 
factors for AAHNPI populations in Hawaii and 
the continental United States (Pobutsky, 
Cuaresma, Kishaba, Noble, Leung, & 
Villaguerte, 2015).  
 
The Present Study  
We undertook a qualitative study to better 
understand health disparities affecting 
AANHPIs and potential ways in which to reduce 
these disparities, by interviewing academic and 
clinical pharmacists and other health 
professionals knowledgeable about these 
populations. We focused on pharmacists 
because, as drug experts, they are well 
positioned to perform wellness- and medication-
related interventions to improve patient 
outcomes, and because an area of interest for 
this research was medication-related disparities. 
Pharmacists have a significant role to play in 
interdisciplinary health care teams in 
communicating with other health care 
professionals and with patients to reduce drug-
related health care disparities (American 
Pharmacists Association Foundation and 
American Pharmacists Association, 2013; 
O'Connell, Korner, Rickles, & Sias, 2007). 
Pharmacist interventions have been shown to 
improve patient adherence and health outcomes 
(Morgado, Morgado, Mendes, Pereira, & 
Castelo-Branco, 2011). The pharmacists who 
were interviewed were in a unique position to 
provide key insights into the health status and 
disparities of AANHPI in Hawaii, because of 
their roles as academics and practicing clinical 
pharmacists with the University of Hawaii at 
Hilo Daniel K. Inouye College of Pharmacy 
(UHH DKICP). The DKICP is the only college 
of pharmacy in the state of Hawaii, and its 
faculty pharmacists are placed in-residence in 
hospitals and ambulatory care clinics throughout 
the state both in metropolitan and rural areas, 
where they are integrated into health care teams 
and work directly with AANHPI patient 
populations (Pezzuto, Ma, & Ma, 2015). 
 
Previous studies that have been conducted to 
assess pharmacist perceptions of their roles in 
healthcare have shown that they have positive 
feelings about providing public health services, 
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but are less confident in their abilities to do this 
and in its importance compared to medicine 
related roles. Few studies have examined 
pharmacist perceptions of health disparities in 
AANHPI populations (Eade, Ferguson, & 
O'Carroll, 2011). One study conducted in New 
Zealand investigated pharmacists’ baseline 
knowledge of health care disparities and 
surveyed their ideas on pharmacist participation 
reducing health disparities. Responses primarily 
focused on education, pharmacist-patient 
relationships, improved cultural competence, 
and pharmacist-patient communication (Aspden, 
Butler, Moore, & Sheridan, 2011). An 
Australian survey of pharmacist perceptions of 
Indigenous Australian health showed that 
pharmacists felt improved access to medicines, 
education, and teamwork with other health care 
professionals could improve Indigenous 
populations’ use of medicines (Stoneman & 
Taylor, 2007). Both the New Zealand and 
Australian studies highlighted the need for 
cultural competence.  
 
To our knowledge, our interviews and 
subsequent findings represent the first 
qualitative study to include pharmacists in order 
to examine their views on health care disparities 
in Hawaii, and notably, to assess their 
perceptions of factors behind these disparities. 
Goals of this study were to examine perceptions 
and factors affecting health disparities affecting 
AANHPIs and to identify the role of 
pharmacists, pharmacy schools, and the U.S. 
Food and Drug Administration (FDA) in 
reducing these disparities. 
 
Methods 
 
Participants  
Purposive sampling was used to identify 
academic pharmacists working in Hawaii, a state 
with a uniquely diverse and dense AAHNPI 
population, and health professionals on the 
mainland United States with experience in 
working with AANHPIs from areas with large 
AANHPI populations (Oakland, CA; San 
Francisco, CA; Boston, MA; and New York, 
NY), as identified by the FDA Office of 
Minority Health. Of the 14 pharmacists from the 
University of Hawaii at Hilo College of 
Pharmacy who were approached, all agreed to 
be interviewed. Of the ten researchers from the 
continental US who were asked to participate via 
an email, four agreed to either be interviewed by 
phone or to respond to questions via email. 
Semi-structured interviews were conducted face-
to-face, when possible, or via telephone. 
 
Measures  
Interview questions are included below. 
Analysis of transcribed data from interviews 
involved extracting basic categories by 
analyzing each response line by line. An 
inductive coding process was constructed using 
NVivo 10 (QSR International, Cambridge, MA) 
that enabled extraction of sections of text that 
related to codes that were uncovered through 
examination of transcripts. Codes were 
collapsed and merged to produce a manageable 
set of basic categories. Each basic category was 
named in order to summarize text sections 
succinctly and in a manner that differentiated it 
clearly from other categories. 
 
• From your personal experience or 
through what you have heard or 
read, do you believe that there are 
gaps in health status of Asians and 
Pacific Islanders in comparison to 
other US populations? If so, in what 
areas and for which groups are there 
inequalities?  
• What do you believe are some of the 
factors that are causing these 
inequalities? 
• Are there gaps in knowledge 
regarding health inequalities 
affecting Asians and Pacific 
Islanders that would benefit from 
additional research, particularly in 
the area of appropriate medication 
use? If so, what type of research 
would be helpful? 
• How might community pharmacists 
work to reduce disparities? 
• How do you feel the College of 
Pharmacy can contribute to reducing 
disparities in appropriate medication 
use? 
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• What role, if any, do you think the 
FDA should play in reducing health 
inequalities and improving 
appropriate medication use? 
 
To minimize the chance of error in coding and 
increase the reliability of the data, two 
researchers, one who had conducted the research 
and a second who did not collect data, coded 
responses independently. Discussion and 
consensus was reached related to systematic 
development of categories. The study was 
approved by University of Hawaii Institutional 
Review Board. 
 
Results 
 
Participant Characteristics  
Fourteen participants were faculty or staff at the 
University of Hawaii at Hilo College of 
Pharmacy. The other four were from the US 
mainland. Half of the participants were male.  
Participants came from a variety of backgrounds 
and a wide range of experiences working with 
AANHPI populations, including retail 
pharmacy, clinical pharmacy, pharmacy 
administration, academia, research, and medical 
practice.  
 
Factors Affecting Disparities  
When asked about factors affecting disparities, 
frequent responses were poor communication, 
socioeconomic status, culture, and access to care 
(Figure 1).  
Figure 1. 
 
Pharmacist Perceptions of Factors Affecting 
Health Disparities. 
Poor Communication. The most common 
response, mentioned by 13 of the 18 
participants, was poor communication due to not 
speaking English fluently, low health literacy, 
and the complexity of medication regimens that 
some patients are prescribed. The responsibility 
of the physician and pharmacist to communicate 
important health information to their patients is 
made challenging when there is no shared 
language; likewise patients will struggle to 
understand complex health terms and regimens. 
Participants stated: 
 
“If you don’t speak English, and 
a lot of our population here does 
not, then they’re not even going 
to understand how to take the 
medication, let alone, how to be 
adherent to it.”  
“Polypharmacy is challenging 
especially when English is not 
their first language, and follow 
up is very difficult.”  
 
Socioeconomic Status. Twelve participants 
pointed to socioeconomic status as a factor 
associated with health disparities for AANHPI 
groups. Some felt that socioeconomic status was 
the main factor behind disparities, rather than 
ethnicity. Participants stated: 
 
“I think the SE Asians, people 
from Vietnam, Thailand, 
Cambodia; they’re probably the 
most unsupported ethnic groups 
among Asian groups. They tend 
to have low socioeconomic 
class level and education 
attainment.”  
“Most of the Pacific population 
I’ve worked with, they do tend 
to be lower socioeconomic... 
But I think that it’s more of a 
socioeconomic thing, not 
necessarily a Pacific Islander or 
Asian thing.” 
 
Culture. Twelve participants pointed to cultural 
causes including use of alternative medicine, 
attitudes and beliefs, reluctance to ask for help, 
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acculturation, and spirituality. One participant 
said: 
“With the Micronesians, it’s 
fear. There’s not a strong 
baseline understanding of 
health, for example they think 
that insulin is dangerous, they 
fear insulin for whatever 
reason.”  
 
Several participants expressed concern that use 
of alternative medicine might interfere with 
patients’ medication adherence. 
 
“The medicinal plants that 
people are using from whatever 
their primary culture is, the 
things that they learned growing 
up from their grandparents, and 
that often has taken much more 
time to go through it than I 
would typically be aware of 
otherwise. And my sense is that 
that plays a role in medication 
adherence.”  
 
Access to Care. Ten participants stated that they 
felt access to care, in terms of financial access, 
the rural nature of health care, transportation, 
and access to quality care, impacted health 
disparities. Financial access is particularly a 
problem due to lower socioeconomic status of 
some AANHPI subgroups. 
 
“Of course, the 800-pound 
gorilla in the room is frequently 
being able to pay for 
medication.” 
“Financial issues are probably 
the backbone of the 
problem…because even if it’s a 
$1 copay, someone living on 
$693 a month will not be able to 
afford that.”  
 
The rural nature of health care delivery for many 
AANHPI patients in Hawaii was also 
mentioned.  
 
“I didn’t even know (how much 
of a role) ethnicity or the 
cultural background plays… 
compared to just living rurally 
and how easy or hard is it to get 
access to health care let alone a 
prescriber a prescription and 
getting that medicine filled and 
taken as directed.”  
 
Other categories mentioned by participants were 
health-related behaviors, stress, genetic 
disposition, and system factors (Figure 1). 
System factors included discrimination, lack of 
social support, and lack of care coordination.  
 
Reducing Disparities: Role of Community 
Pharmacists  
While the majority of participants (15/18) felt 
that community pharmacists could impact health 
disparities, three participants said that they were 
unsure of what the role of a community 
pharmacist could be. The pharmacists who felt 
positively about community pharmacists’ roles 
in reducing disparities made suggestions as to 
how they might be able to reduce gaps in health 
status affecting AANHPIs (Table 1). These 
included expanded consultation time, improved 
translation services, increased cultural 
awareness, and an increased focus on outcomes.  
 
Table 1. 
 
General Strategies to Reduce Health 
Disparities Among AANHPIs. 
 Strategy 
In general Change reimbursement model for 
pharmacists to emphasize 
counseling 
Foster community involvement 
Focus on prevention of disease 
rather than treatment 
 
 
 “(Community pharmacists) 
really need to kind of step away 
from the counter and get to 
know their patients, and there’s 
been a big push, I think, in 
pharmacy to do that to get out of 
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the fishbowl and actually talk to 
their patients.”  
 
One participant emphasized the importance of 
an increased focus on outcomes.  
 
“I am in the belief that we are 
sort of on the brink of, you 
know, community pharmacies 
are not going to be sort of the 
money makers that they have in 
the past, and they’re going to 
have to show some outcomes on 
chronic diseases especially 
health disparities.” 
 
Reducing Disparities: Role of College of 
Pharmacy  
All fourteen participants who were asked what 
the role of the University of Hawaii at Hilo 
Daniel K. Inouye College of Pharmacy could 
play in reducing disparities stated that the 
College could contribute to improving health 
care by educating pharmacy students to be 
clinically competent and culturally aware 
professionals (Table 1). They also felt that the 
College could spearhead progression in 
pharmaceutical care by collaborating with 
physicians and programs, and by continuing its 
community outreach efforts. The four 
participants who were unfamiliar with the 
Daniel K. Inouye College of Pharmacy were not 
asked to provide a response to this question. 
 
“(Emphasize) that the more 
important aspects of practice of 
pharmacy is patient focused 
care. That everything should 
revolve around the patient, and 
if you don’t interact with the 
patient, then you’re not really 
helping them.”  
“We have students with intimate 
knowledge of some of these 
populations…I think we need to 
leverage those student resources 
by funding projects that will 
work to screen. But, we need to 
take a step further than 
screening and collaborate with 
nurse practitioners, doctors, 
PAs, somebody with prescribing 
authority or develop a 
collaborative practice agreement 
with a pharmacy faculty staff.”  
 
Reducing Disparities: Role of the U.S. Food 
and Drug Administration (FDA)  
When asked what role the FDA should play in 
reducing disparities, responses were mixed.  Ten 
participants identified potentials roles for the 
FDA in reducing disparities. One participant 
said the FDA should consider medication 
adherence: 
 
“…[The FDA] should be 
approving medications are 
going to help with medication 
adherence. Whether it’s through 
appropriate dosing and dosing 
times…approving me-too drugs 
that may end up costing the 
patient less or improving their 
ability to adhere to medication.” 
 
In contrast, three participants felt the FDA really 
did not have a large role, and four participants 
were uncertain of whether the FDA should play 
a role, stating: 
 
“The FDA may be able to play a 
role in making drug therapy 
more accessible, also maybe 
not. I think that’s more of a 
political question than a 
regulatory question. They’re a 
regulatory agency.”  
“I think it’s a noble idea. I 
wouldn’t say that they 
shouldn’t, but I would be 
surprised to hear that they had a 
lot of efforts to do stuff.”  
 
Three participants others pointed out the need to 
encourage research involving AANHPIs to a 
greater extent:  
 
“…require more ethnicities, 
more ethnic background to be 
involved in clinical research, 
trials, that might be a way that 
clinicians can convince our 
Hu, D., Juarez, D., Lin, V., Goo, R., Yeboah, M., Castillo, T.  / Californian Journal of Health Promotion 2015, Volume 13, Issue 2, 
37-47. 
 
 43 
minority population or 
subgroups…to accept and agree 
that these medications will help 
them.” 
 
Aiding with translation of materials for 
AANHPIs was also mentioned by one 
participant as a potential role for the FDA:  
 
“…putting patient information 
pamphlets in different Pacific 
Island languages. I think that 
Marshallese, Chuukese, Yap, 
these are the languages. That 
might be one good way the 
FDA could help.”  
 
Discussion 
 
Hawaii has a large and diverse AANHPI 
community, with significant gaps in health 
status. Our findings from interviews with 
academic pharmacists and health care 
professionals familiar with the role of 
pharmacists and with the needs of AANHPI 
populations provided insights into avenues 
through which disparities can be addressed. 
These insights are valuable given the evolution 
of the role of pharmacists in health care 
(Kenreigh & Wagner, 2006).  
 
While a major focus of our interviews were 
centered around medication-related health care 
disparities, it became clear that our participants 
felt that there were larger factors which were the 
cause of many disparities. Health care 
professionals in our study felt that the top three 
categories of factors affecting health disparities 
for AANHPIs were communication, 
socioeconomic status and culture. In terms of 
communication, participants focused on limited 
English language proficiency as a barrier. This 
has been cited by others as the ‘lowest common 
denominator of cultural sensitivity’ and a barrier 
to optimal health care (Rogler, Malgady, 
Costantino, & Blumenthal, 1987). Participants 
suggested that translation, for both oral and 
printed materials, was an important aspect of 
health care communication in retail and clinical 
pharmacy settings. 
 
Participants also felt that socioeconomic status 
was one of the most important factors behind 
health care disparities. Several participants felt 
that its impact was so great that socioeconomic 
status, rather than ethnicity, was a prevailing 
factor behind gaps in health care. While the 
impact of socioeconomic status on health status 
is well known, it is also often an “ignored 
determinant of the nation’s health” (Isaacs & 
Schroeder, 2004).  Though deemed to be 
extremely important, a detailed discussion of 
how to address economic inequality was beyond 
the scope of this study. 
 
The impact of culture was seen to have a 
significant impact on patients’ ability to 
understand medication use, their attitudes 
towards Western medicines, and their 
willingness to seek help from health care 
professionals (Kreuter & McClure, 2004). 
Cultural competency, a known issue in 
healthcare, was highlighted as a necessary aspect 
of care provided by pharmacists and other health 
care professionals (Hirano, 2012).  Despite 
reports from the Institute of Medicine (IOM) 
highlighting cultural competency training as a 
means of addressing racial and ethnic disparities 
in care, a survey of resident physicians reported 
that less than half felt “well-prepared” or “very 
well-prepared” to treat patients from diverse 
cultures (Weissman, Betancourt, Campbell, 
Park, Kim, Clarridge, et al., 2005). Hence, while 
pharmacy schools offer training in cultural 
competency, more continuing education may be 
needed for community pharmacists, relating to 
specific populations. Current Accreditation 
Council for Pharmacy Education (ACPE) 
standards require pharmacy programs to ensure 
that the curriculum addresses patient safety, 
cultural appreciation, health literacy, and health 
care disparities (Accreditation Council for 
Pharmacy Education, 2011). 
 
Participants felt that pharmacists are well-
positioned to address the needs of AANHPI 
patients as accessible health care professionals 
and pharmacotherapy experts, particularly by 
being effective educators to patients. However, 
participants felt that the demands of retail 
pharmacy responsibilities often created a barrier 
to patient education due to the time constraints 
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imposed by the burden of filling prescriptions. 
Participants felt that the role of a pharmacist has 
been expanding and will continue to evolve in 
the future to include more patient- and outcome-
focused efforts. These sentiments have been 
shared by others in the literature (Hilsenrath, 
Woelfel, Shek, & Ordanza, 2012; Law, 
Okamoto, & Brock, 2009; Twigg, Poland, 
Bhattacharya, Desborough, & Wright, 2012). 
Presently, there is a lack of data describing 
pharmacists’ abilities to address health literacy 
gaps, and this area merits research as patients 
rely on pharmacists to provide them with 
information necessary to the safe and effective 
use of their medications (Tkacz, Metzger, & 
Pruchnicki, 2008).  
 
Most participants felt the College of Pharmacy 
should continue to support student participation 
in community service events, such as health 
fairs, to encourage patient-centered care, and to 
advocate for policies that promote high quality 
pharmaceutical care.  
 
In regard to the role of the FDA, several 
participants felt the FDA may be able to 
improve enrollment of AANHPIs into clinical 
trials, as there is a lack of information on Asian 
American responses to medications and dosing 
standards may not be appropriate to Asian 
Americans due to their smaller size on average. 
These concerns echo a recent article which 
asserted that recruitment of minorities and 
adequate representation in clinical trials is vital 
to closing health care gaps (Brown, Lee, 
Schoffman, King, Crawley, & Kiernan, 2012). 
Others felt the FDA could help with translation 
patient information into Pacific Islander 
languages and funding investigators in health 
disparities research. 
 
Our findings provide evidence that pharmacists 
in Hawaii felt similarly to the pharmacists in 
Australia and New Zealand regarding the 
importance of patient education in addressing 
health disparities for Indigenous Australian and 
Maori populations. Similarly to the pharmacist 
participants in the Australian survey, our 
participants expressed a concern that time 
constraints imposed by their primary roles 
would limit their ability to participate in 
activities that could address health care 
disparities (Eade, Ferguson, & O'Carroll, 2011; 
Aspden, Butler, Moore, & Sheridan, 2011). 
 
Of note, an article published in 2012 by faculty 
from the UNC Eshelman School of Pharmacy 
noted that less than 3% of accredited pharmacy 
colleges and schools are promoting and 
providing formal curricular programming in 
rural pharmacy health, citing the need for 
qualified pharmacy practitioners in rural areas 
(Joyner, O'Connor, Thrasher, & Blouin, 2012). 
It is for this very reason that the University of 
Hawaii chose to place the DKICP in a rural area 
on the island of Hawaii, as opposed to a more 
urban center in Honolulu on the island of Oahu. 
A recently published article by the Dean of the 
DKICP noted that “Most recent data that 
describes the desperate shortage of health care 
professionals in rural Hawai‘i justifies the [rural] 
placement of our program” (Pezzuto, Ma, & Ma, 
2015). 
 
Limitations  
There are some limitations in this study that 
should be mentioned. As only one interviewer 
collected the data, research quality may be 
influenced by the researcher's personal biases. 
We attempted to lessen any impact by 
transcribing the data and having another 
researcher independently code and compare 
results. Moreover, as our interviews were 
primarily focused on health care providers, 
further research is needed to gain an 
understanding of the patient perspective of the 
role of pharmacists, pharmacy schools, and the 
FDA in improving the health of vulnerable 
populations.  
 
Conclusion 
 
Despite these limitations, our study adds to the 
literature in that it explores an understudied area 
involving pharmacist and other health care 
professionals’ perceptions of health disparities 
and ways in which they might be reduced. As 
many of the disparities are in chronic conditions 
and appropriate medication use is a key 
component of improved health status, we believe 
the insights gained from our interviews will help 
to target interventions to address health 
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disparities. Increased health data collection, 
reporting, and dissemination for the AANHPIs, 
along with greater inclusion in research studies 
examining effective interventions, needs to be a 
priority if we are to reduce gaps in health status 
for AANHPIs. 
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